When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALPMY - IPO Update: Zentalis Pharmaceuticals Aims For $130 Million IPO
Astellas Pharma Inc. ADR
Quick Take
Zentalis Pharmaceuticals (ZNTL) intends to raise $130 million from an IPO of its common stock, according to an amended S-1/A registration statement.
The company is advancing a pipeline of potential drug treatments for breast cancer, solid tumors and other cancers.
ZNTL has two significant collaborations and the IPO is priced at the high end of the typical range for Phase 1 / 2 stage biopharmas with large market opportunities.
The stock may be appropriate for long-term hold life science investors.